Phenotypic changes in cultured smooth muscle cells: limitation or opportunity for tissue engineering of hollow organs?

被引:34
作者
Huber, Alexander [1 ]
Badylak, Stephen F. [1 ]
机构
[1] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA
基金
美国国家卫生研究院;
关键词
tissue engineering; smooth muscle cell; differentiation; cell culture; in vitro; cell expansion; IN-VITRO; URINARY-BLADDER; STEM-CELLS; MOLECULAR REGULATION; COLLAGEN SPONGE; DIFFERENTIATION; REPLACEMENT; SCAFFOLDS; HYBRID; MODEL;
D O I
10.1002/term.451
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Smooth muscle cells (SMCs) are typically used as a cell source for the reconstruction of hollow organs by conventional tissue engineering techniques. However, the necessity for and advantage of the use of tissue-specific SMCs are unknown. The present study investigated the phenotypic changes that occur following isolation and in vitro expansion of rat SMC populations isolated from three different tissues: the aorta, oesophagus and urinary bladder. rSMCs were isolated by enzymatic dispersion and expanded by conventional cell culture techniques, yielding microscopically homogeneous populations. SMC phenotypes were monitored according to their expression of marker proteins during the first two passages. Two of the three SMC populations (rSMC-a and rSMC-e) showed a marked change in their marker protein profiles during the first two passages, which resulted in a homogeneous phenotype that was neither fully contractile nor fully synthetic. SMCs from the urinary bladder did not show such a shift. Differences between the three rSMC populations were observed with regard to proliferative activity and gene expression patterns, suggesting the retention of some tissue-specific cell characteristics. In summary, phenotypic changes in SMCs occur as a result of conventional cell isolation and expansion techniques, thus questioning the necessity for a tissue-specific cell source for regenerative medicine applications. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 51 条
[1]  
Aikawa M, 1997, CIRCULATION, V96, P82
[2]   Engineering organs [J].
Atala, Anthony .
CURRENT OPINION IN BIOTECHNOLOGY, 2009, 20 (05) :575-592
[3]   Age-dependent vascular endothelial growth factor expression and angiogenic capability of bladder smooth muscle cells: implications for cell-seeded technology in bladder tissue engineering [J].
Azzarello, Joseph ;
Kropp, Bradley P. ;
Fung, Kar-Ming ;
Lin, Hsueh-Kung .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2009, 3 (08) :579-589
[4]   Development of a seeded scaffold in the great omentum:: Feasibility of an in vivo bioreactor for bladder tissue engineering [J].
Baumert, Heru ;
Simon, Pascal ;
Hekmati, Mehrak ;
Fromont, Gaelle ;
Levy, Maryline ;
Balaton, Andre ;
Molinie, Vincent ;
Malavaud, Bernard .
EUROPEAN UROLOGY, 2007, 52 (03) :884-892
[5]  
Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]
[6]   Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease [J].
Bouchez, Gaelle ;
Sensebe, Luc ;
Vourc'h, Patrick ;
Garreau, Lucette ;
Bodard, Sylvie ;
Rico, Angelique ;
Guilloteau, Denis ;
Charbord, Pierre ;
Besnard, Jean-Claude ;
Chalon, Sylvie .
NEUROCHEMISTRY INTERNATIONAL, 2008, 52 (07) :1332-1342
[7]  
Christen T, 1999, CIRC RES, V85, P99
[8]   Development of hepatic tissue engineering [J].
Fiegel, Henning Cornelius ;
Kneser, Ulrich ;
Kluth, Dietrich ;
Metzger, Roman ;
Till, Holger ;
Rolle, Udo .
PEDIATRIC SURGERY INTERNATIONAL, 2009, 25 (08) :667-673
[9]   Tissue Engineered Bone Grafts: Biological Requirements, Tissue Culture and Clinical Relevance [J].
Froehlich, Mirjam ;
Grayson, Warren L. ;
Wan, Leo Q. ;
Marolt, Darja ;
Drobnic, Matej ;
Vunjak-Novakovic, Gordana .
CURRENT STEM CELL RESEARCH & THERAPY, 2008, 3 (04) :254-264
[10]  
Furukawa KS, 2002, CELL TRANSPLANT, V11, P475